Clinical Trials Browser

Terminated × Ovarian Neoplasms × entinostat × Clear all

NCT03924245 2022-04-04

Olaparib and Entinostat in Patients With Recurrent, Platinum-Refractory, Resistant Ovarian, Primary Peritoneal, Fallopian Tube Cancers

Phase 1 Terminated

Fallopian Tube Neoplasms, Ovarian Neoplasms, Endometrial Neoplasms